Literature DB >> 1190344

Transalveolar transport of large polar solutes (sucrose, inulin, and dextran).

J Theodore, E D Robin, R Gaudio, J Acevedo.   

Abstract

The in vivo transalveolar transport of three large polar solutes, sucrose, inulin, and dextran (mol wt 60,000-90,00), was compared with the transport of urea in saline-filled dog lung. Apparent permeability coefficents (p', in cm X sec-1 X 10(6)) were as follows; urea: 2.4 +/- 0.28 (SD) greater than sucrose: 0.64 +/- 0.31 (P less than 0.001) greater than inulin: 0.12 +/- .05 (P less than 0.001)--not different from dextran (mol wt 60,000-90,000): 0.08 +/- .02 (P greater then .01). Calculation of the resistance of the alveolar epithelium compared to total barrier resistance for the various solutes indicates that approximately 90% of the total resistance resides in the alveolar epithelium. Comparison of the ratio of permeability coefficients to the ratio of free-diffusion coefficients in water shows similar values for the three large polar solutes, suggesting that permeation through the alveolar epithelium occurs by means of water-filled channels. The values for permeability coefficients of alveolar epithelium fit into the spectrum of values reported for other epithelial structures (including gall bladder, frog skin, and toad bladder); it seems to have a system of channels with a small number of wide "pores" (greater than 80 A) that permit permeation of large polar solutes and is not a relatively homogeneous structure.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1190344     DOI: 10.1152/ajplegacy.1975.229.4.989

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  15 in total

1.  Monolayers of human alveolar epithelial cells in primary culture for pulmonary absorption and transport studies.

Authors:  K J Elbert; U F Schäfer; H J Schäfers; K J Kim; V H Lee; C M Lehr
Journal:  Pharm Res       Date:  1999-05       Impact factor: 4.200

2.  A pore transport model for pulmonary alveolar epithelium.

Authors:  T Chandra; I F Miller; D B Yeates
Journal:  Ann Biomed Eng       Date:  1992       Impact factor: 3.934

3.  The air-blood barrier in the human lung. A freeze-fracture study.

Authors:  H Bartels
Journal:  Cell Tissue Res       Date:  1979-05-18       Impact factor: 5.249

4.  Permeability of peptides and proteins in human cultured alveolar A549 cell monolayer.

Authors:  S Kobayashi; S Kondo; K Juni
Journal:  Pharm Res       Date:  1995-08       Impact factor: 4.200

5.  The effect of ethchlorvynol on pulmonary ultrastructure in dogs.

Authors:  L C Dearden; F L Glauser; D Smeltzer
Journal:  Am J Pathol       Date:  1977-06       Impact factor: 4.307

6.  Bacterial ventilator-associated pneumonia: bronchoalveolar lavage results are not influenced by dilution.

Authors:  Olivier Baldesi; Fabrice Michel; Christophe Guervilly; Nathalie Embriaco; Aliocha Granfond; Bernard La Scola; Henri Portugal; Laurent Papazian
Journal:  Intensive Care Med       Date:  2009-02-03       Impact factor: 17.440

7.  Pulmonary disposition of roxithromycin (RU 28965), a new macrolide antibiotic.

Authors:  J Chastre; P Brun; J B Fourtillan; P Soler; G Basset; C Manuel; J L Trouillet; C Gibert
Journal:  Antimicrob Agents Chemother       Date:  1987-09       Impact factor: 5.191

8.  Fibronectin in human bronchopulmonary lavage fluid. Elevation in patients with interstitial lung disease.

Authors:  S I Rennard; R G Crystal
Journal:  J Clin Invest       Date:  1982-01       Impact factor: 14.808

9.  Analysis of vancomycin entry into pulmonary lining fluid by bronchoalveolar lavage in critically ill patients.

Authors:  C Lamer; V de Beco; P Soler; S Calvat; J Y Fagon; M C Dombret; R Farinotti; J Chastre; C Gibert
Journal:  Antimicrob Agents Chemother       Date:  1993-02       Impact factor: 5.191

10.  99mTc-DTPA clearance measured by a dual head gamma camera in healthy subjects and patients with sarcoidosis. Studies of reproducibility and relation to bronchoalveolar lavage findings.

Authors:  S Thunberg; K Larsson; A Eklund; E Blaschke
Journal:  Eur J Nucl Med       Date:  1989
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.